Characterization of Central Pain Syndrome in Survivors of Head and Neck Cancer
Characterization of Central Pain Syndrome in Survivors of Head and Neck Cancer
This is a cross-sectional pilot study of head and neck cancer survivors who have completed multi-modal treatment to assess and characterize the presence of distinct pain syndromes.
Primary objectives:
Exploratory objectives:
- DNA, RNA, and plasma will be collected for genomic, transcriptomic, and proteomic studies. Results will be vertically integrated along with the results of clinical studies described within this protocol to identify targets for future correlative studies.
Inclusion Criteria:
Patients with histologically proven head and neck cancer
Patients without a diagnosis of head and neck cancer (up to 10 patients, see below)
Completed multi-modality therapy a minimum of 6 weeks prior to study entry.
Willing and able to provide informed consent
All participants must be at least 21 years of age
Able to speak English
Exclusion Criteria: